Skip to main content

Find Clinical Trials

Home
Conditions
EGFR Exon 20 Insertion Mutations

Clinical trial condition

EGFR Exon 20 Insertion Mutations

Explore clinical trials studying EGFR Exon 20 Insertion Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

EGFR Exon 20 Insertion Mutations trial results

Recruiting

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

NCT06816992

Conditions: EGFR Exon 20 Insertion Mutations, EGFR-mutated NSCLC, NSCLC, +1 more
Locations: NYU Langone Health New York, United States

Virginia Cancer Specialists Fairfax, Virginia, United States

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

The Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details